Navigation Links
Campbell Alliance Brand Management Practice to Present at EyeForPharma's Oncology Summit USA and Oncology Market Access Europe Conference
Date:3/10/2009

RALEIGH, N.C., March 10 /PRNewswire/ -- Campbell Alliance, the leading management consulting firm specializing in the pharmaceutical and biotech industry, today announced that Ashwin Dandekar, Vice President, Brand Management Practice, will present a session at EyeforPharma's Oncology Summit USA on March 30 and 31, 2009 at the Boston Park Plaza Hotel in Boston, Massachusetts. Dr. Dandekar will also present a workshop at EyeForPharma's Oncology Market Access Europe Conference, scheduled for April 22 and 23, 2009 at the Zurich Marriott Hotel in Zurich, Switzerland.

Dr. Dandekar's presentation at EyeforPharma's Oncology Summit USA is scheduled for 3:30 pm March 30 as a part of "Session 3: Market Access and Early Commercialization". His presentation, titled "The Building Blocks of Successful Oncology Commercialization," will examine the four building blocks for maximizing the commercial value of new oncology products. Specifically, the presentation will focus on developing long-term vision for products in tandem with comprehensive market-entry strategies, creating winning labels and development programs, assessing and developing markets, and building the company's infrastructure and resources to put into action commercialization strategies.

At EyeforPharma's Oncology Market Access Europe Conference, Dr. Dandekar will present a workshop at 2:00 pm on April 20. His workshop, also titled "The Building Blocks of Successful Oncology Commercialization," will similarly examine the essential elements of maximizing commercial value for oncology products, but will focus on commercialization in European markets.

"The oncology market is undoubtedly complicated as products themselves are complex, market competition is fierce, and there are many strategic and organizational challenges that result from the specialized nature of the products," Dr. Dandekar said. "Consequently, oncology product commercialization can b
'/>"/>

SOURCE Campbell Alliance
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related biology technology :

1. Campbell Alliance Hires Joe Dillon, Expands Business Development Practice
2. Campbell Alliance Sales Practice to Present at CBIs Leadership Summit on Evolving the Pharma Sales Model
3. Nader Naeymi-Rad Appointed Chief Operating Officer at Campbell Alliance
4. Darius Naigamwalla Appointed Senior Vice President and Head of the Brand Management Practice at Campbell Alliance
5. Pharmaceutical Institute, in Collaboration With Campbell Alliance, Releases Second Edition of Breakthrough Book on the Inner Workings of the Pharmaceutical Industry
6. Campbell Alliance Clinical Development Practice to Conduct Two Workshops at 44th DIA Annual Meeting
7. Campbell Alliance Trade and Distribution Practice to Speak at CBIs Commercial Contracts and Chargeback Management Conference
8. Campbell Alliance Sales Practice to Present Workshop at SPBT Annual Conference
9. Campbell Alliance Clinical Development Practice to Present Session on Global EDC Rollout at Clinical Trials Congress, Europe
10. Campbell Alliance Adds Doug Linton, Former Cardinal Health Executive, to Executive Advisory Group
11. Campbell Alliance Managed Markets Practice to Take a Leadership Role at the CBI Forum on Effective Product Pricing and Modeling Strategies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... 23, 2014 /PRNewswire/ - BioAmber Inc. (NYSE: ... sustainable chemicals, today announced that the underwriters of its ... to purchase an additional 420,000 shares of common ... per share, less underwriting discounts and commissions, in ... of 2,800,000 shares of common stock, bringing the ...
(Date:7/23/2014)... , July 23, 2014 ... ), the global specialty biopharmaceutical company, and ArmaGen, ... a worldwide licensing and collaboration agreement for AGT-182, ... potential treatment of both the central nervous system ... syndrome (MPS II). This collaboration strengthens Shire,s rare ...
(Date:7/23/2014)... , July 23, 2014  Sofinnova Ventures, a ... today announced the closing of Sofinnova Venture Partners IX, ... in excess of the initial fund target of $425 ... build successful biotechnology companies. Consistent with recent funds, SVP ... later stage clinical programs, along with select investments in ...
(Date:7/23/2014)... California (PRWEB) July 23, 2014 With the ... in HD resolution for more than 15 minutes, Fastec Imaging ... the world of high speed imaging. “Finally, a high speed ... camera we use in our everyday lives.” proclaims Matt Kearney, ... Fastec has always been to demystify and simplify the traditionally ...
Breaking Biology Technology:BioAmber announces exercise in full of underwriters' option in connection with previously priced follow-on offering 2BioAmber announces exercise in full of underwriters' option in connection with previously priced follow-on offering 3Shire Enters Strategic Licensing and Collaboration Agreement With ArmaGen 2Shire Enters Strategic Licensing and Collaboration Agreement With ArmaGen 3Shire Enters Strategic Licensing and Collaboration Agreement With ArmaGen 4Shire Enters Strategic Licensing and Collaboration Agreement With ArmaGen 5Sofinnova Raises $500 Million Biotech Venture Fund 2Fastec Imaging Introduces the First High Speed Camcorder 2Fastec Imaging Introduces the First High Speed Camcorder 3
... ... the Development and Optimization of Crystallization Processes, a method will be presented which facilitates ... of qualitative supersaturation trajectories. , ... (PRWEB) October 9, 2009 -- The quantitative use of in situ ATR-FTIR ...
... Medicago Inc. (TSX-V: MDG), a biotechnology company focused ... on proprietary manufacturing technologies and Virus-Like Particles (VLPs), ... proof of concept contract by the U.S. Army ... Edgewood Chemical Biological Center ("ECBC") Research & Technology ...
... ... , ... York (PRWEB) October 8, 2009 -- iCardiac Technologies, Inc., a global leader in advanced ... has awarded iCardiac a comprehensive cardiac safety study. iCardiac will provide end-to-end study ...
Cached Biology Technology:Calibration Free Supersaturation Assessment and Control for the Development and Optimization of Crystallization Processes 2Medicago awarded contract by the U.S. Army to explore applications of its plant-based technology in renewable energy 2Global Pharmaceutical Company Awards Comprehensive Cardiac Safety Study to iCardiac 2
(Date:7/23/2014)... . , Proteins ... and transmit signals. To perform these manifold tasks, they ... Planck Institute for Developmental Biology in Tbingen have now ... acid chains even when their three-dimensional shapes differ significantly. ... from common precursors. Presumably, in the course of evolution ...
(Date:7/23/2014)... As local and national governments struggle to deal with ... now refining the picture of just how much there ... the ACS journal Environmental Science & Technology , ... that developed countries discard floods into just seven developing ... people who live there. , Knut Breivik and colleagues ...
(Date:7/23/2014)... starfish, and corals have in common? Aside from ... that use calcium from their environment to create ... protection. , The July issue of The ... Laboratory, addresses the challenges faced by these species ... carbon dioxide rises, the world,s oceans are becoming ...
Breaking Biology News(10 mins):Protein evolution follows a modular principle 2Calcification in changing oceans explored in special issue of The Biological Bulletin 2
... , NEW YORK, Oct. 27 Global Rainmakers, Inc., ... today announced that the company has exited its "stealth" ... of technologies designed to leverage cutting-edge biometric security offerings. ... spent tens of millions of dollars to develop and ...
... blood, normally take the shape of circular cushions with a ... an asymmetrical slipper shape. A team of physicists have ... for this deformation, as well as how the deformation in ... mechanisms involved in arterial disease and other blood flow-related ailments. ...
... Contrary to a national trend, more and more ... in math and science. Thanks to a $307,277 grant ... in the sciences at RutgersCamden will receive unprecedented support ... their degrees. Through a new RutgersCamden program titled ...
Cached Biology News:Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 2Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 3NSF grant supports Rutgers-Camden program for science majors 2NSF grant supports Rutgers-Camden program for science majors 3
... CHEMICON MDR1 Shift Assay provides a convenient method ... upon transport of MDR1 substrates. Thus, the kit ... which small molecules act as transport substrates for ... the presence of MDR1 substrates, the MDR1 Shift ...
... microarrays are derived from frozen embedded tissue ... control procedures to ensure the highest quality. ... in one block, sectioned at a thickness ... slides. Sections are large (3-5 mm in ...
... Zyagen tissue microarrays are derived from frozen ... rigorous quality control procedures to ensure the ... manually assembled in one block, sectioned at ... coated slides. Sections are large (3-5mm in ...
... from Paraffin embedded tissue blocks, which are ... ensure the highest quality. Tissues of each ... sectioned at a thickness of 5 microns ... large (3-5mm in diameter) in comparison to ...
Biology Products: